General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0UYIOG
ADC Name
YL-212
Synonyms
YL212; YL 212
   Click to Show/Hide
Organization
Suzhou Medilink Therapeutics Ltd.; Zai Lab Ltd.
Drug Status
Investigative
Indication
In total 1 Indication(s)
Small cell lung cancer
Clinical candidate
.
Antibody Name
Undisclosed
Antigen Name
Delta-like protein 3 (DLL3)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed
Conjugate Type
MediLinks proprietary TAMLIN platform.